Entellus Medical has raised $35 million through a round of series E funding. The funding round was led by Covidien Ventures, with existing investors SV Life Sciences, Essex Woodlands, Split Rock Partners and Greenspring Associates also participating.
Entellus Medical will utilize the proceeds to finance its current operations and for the commercialization of its multiple product lines. Entellus Medical is a medical device company that provides minimally invasive solutions for treatment of patients with chronic sinusitis.
Click here for the release from Entellus Medical.